English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/191865
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.

AuthorsSanz-Ortega, Laura; Rojas, José M.; Marcos, Ana.; Portilla, Yadileiny; Stein, Jens V.; Barber, Domingo F.
KeywordsCell-based therapy
T cell
Magnetic nanoparticle
Magnetic retention
Lymph node
Issue DateJan-2019
PublisherBioMed Central
CitationJournal of Nanobiotechnology 17 (1):14 (2019)
AbstractBACKGROUND:T lymphocytes are highly dynamic elements of the immune system with a tightly regulated migration. T cell-based transfer therapies are promising therapeutic approaches which in vivo efficacy is often limited by the small proportion of administered cells that reaches the region of interest. Manipulating T cell localisation to improve specific targeting will increase the effectiveness of these therapies. Nanotechnology has been successfully used for localized release of drugs and biomolecules. In particular, magnetic nanoparticles (MNPs) loaded with biomolecules can be specifically targeted to a location by an external magnetic field (EMF). The present work studies whether MNP-loaded T cells could be targeted and retained in vitro and in vivo at a site of interest with an EMF. RESULTS:T cells were unable to internalize the different MNPs used in this study, which remained in close association with the cell membrane. T cells loaded with an appropriate MNP concentration were attracted to an EMF and retained in an in vitro capillary flow-system. MNP-loaded T cells were also magnetically retained in the lymph nodes after adoptive transfer in in vivo models. This enhanced in vivo retention was in part due to the EMF application and to a reduced circulating cell speed within the organ. This combined use of MNPs and EMFs did not alter T cell viability or function. CONCLUSIONS:These studies reveal a promising approach to favour cell retention that could be implemented to improve cell-based therapy.
Publisher version (URL)http://dx.doi.org/10.1186/s12951-019-0440-z.
Appears in Collections:(CNB) Artículos
Files in This Item:
File Description SizeFormat 
12951_2019_Article_440.pdfArtículo principal7,29 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.